APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Selected research

Industry Growth & Trends

Global Gabapentin Industry Growth and Trends Forecast to 2032

21 December 2025111 pages

Choose your research edition.

Industry ResearchGabapentin Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gabapentin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.

North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.

Read the full market overview

In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.

Report Scope

This report provides a structured, data-driven view of the global Gabapentin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gabapentin market size, estimates, and forecasts are presented in terms of sales volume (M Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gabapentin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gabapentin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gabapentin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gabapentin Market by Company

Pfizer

Assertio Therapeutics

TEVA

Mylan

Arbor Pharma

Novartis

Apotex

Sun Pharmaceutical

Aurobindo Pharma

Intas

Amneal

Marksans Pharma

Glenmark

Alkem

Jiangsu Enhua

Jiangsu Hengrui

Sailike

Gabapentin Segment by Type

Capsule

Tablet

Gabapentin Segment by Application

Epilepsy

Neuropathic Pain

Restless Legs Syndrome

Others

Gabapentin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gabapentin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Tablet Table 3. Global Gabapentin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Gabapentin Sales by Type (2021-2026) & (M Unit) Table 5. Global Gabapentin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Gabapentin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Gabapentin Sales Market Share in Value by Type (2021-2026) Table 8. Global Gabapentin Price by Type (2021-2026) & (USD/Unit) Table 9. Global Gabapentin Sales by Type (2027-2032) & (M Unit) Table 10. Global Gabapentin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Gabapentin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Gabapentin Sales Market Share in Value by Type (2027-2032) Table 13. Global Gabapentin Price by Type (2027-2032) & (USD/Unit) Table 14. North America Gabapentin Sales by Type (2021-2026) & (M Unit) Table 15. North America Gabapentin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Gabapentin Sales by Type (2021-2026) & (M Unit) Table 17. Europe Gabapentin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Gabapentin Sales by Type (2021-2026) & (M Unit) Table 19. Asia-Pacific Gabapentin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Gabapentin Sales by Type (2021-2026) & (M Unit) Table 21. Latin America Gabapentin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Gabapentin Sales by Type (2021-2026) & (M Unit) Table 23. Middle East and Africa Gabapentin Sales by Type (2021-2026) & (US$ Million) Table 24. Gabapentin Industry Trends Table 25. Gabapentin Industry Drivers Table 26. Gabapentin Industry Opportunities and Challenges Table 27. Gabapentin Industry Restraints Table 28. Global Gabapentin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Gabapentin Revenue Market Share by Company (2021-2026) Table 30. Global Gabapentin Sales by Company (2021-2026) & (M Unit) Table 31. Global Gabapentin Sales Share by Company (2021-2026) Table 32. Global Gabapentin Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Gabapentin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Gabapentin Major Company Production Sites and Headquarters Table 35. Global Gabapentin Company, Product Type & Application Table 36. Global Gabapentin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Gabapentin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Gabapentin Sales by Region (2021-2026) & (M Unit) Table 41. Global Gabapentin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Gabapentin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Gabapentin Sales Market Share in Value by Region (2021-2026) Table 44. Global Gabapentin Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Gabapentin Sales by Region (2027-2032) & (M Unit) Table 46. Global Gabapentin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Gabapentin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Gabapentin Sales Market Share in Value by Region (2027-2032) Table 49. Global Gabapentin Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Gabapentin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Gabapentin Sales by Application (2021-2026) & (M Unit) Table 52. Global Gabapentin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Gabapentin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Gabapentin Sales Market Share in Value by Application (2021-2026) Table 55. Global Gabapentin Price by Application (2021-2026) & (USD/Unit) Table 56. Global Gabapentin Sales by Application (2027-2032) & (M Unit) Table 57. Global Gabapentin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Gabapentin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Gabapentin Sales Market Share in Value by Application (2027-2032) Table 60. Global Gabapentin Price by Application (2027-2032) & (USD/Unit) Table 61. North America Gabapentin Sales by Application (2021-2026) & (M Unit) Table 62. North America Gabapentin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Gabapentin Sales by Application (2021-2026) & (M Unit) Table 64. Europe Gabapentin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Gabapentin Sales by Application (2021-2026) & (M Unit) Table 66. Asia-Pacific Gabapentin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Gabapentin Sales by Application (2021-2026) & (M Unit) Table 68. Latin America Gabapentin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Gabapentin Sales by Application (2021-2026) & (M Unit) Table 70. Middle East and Africa Gabapentin Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Pfizer Gabapentin Product Portfolio Table 75. Pfizer Recent Development Table 76. Assertio Therapeutics Company Information Table 77. Assertio Therapeutics Business Overview Table 78. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Assertio Therapeutics Gabapentin Product Portfolio Table 80. Assertio Therapeutics Recent Development Table 81. TEVA Company Information Table 82. TEVA Business Overview Table 83. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. TEVA Gabapentin Product Portfolio Table 85. TEVA Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Mylan Gabapentin Product Portfolio Table 90. Mylan Recent Development Table 91. Arbor Pharma Company Information Table 92. Arbor Pharma Business Overview Table 93. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Arbor Pharma Gabapentin Product Portfolio Table 95. Arbor Pharma Recent Development Table 96. Novartis Company Information Table 97. Novartis Business Overview Table 98. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Novartis Gabapentin Product Portfolio Table 100. Novartis Recent Development Table 101. Apotex Company Information Table 102. Apotex Business Overview Table 103. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Apotex Gabapentin Product Portfolio Table 105. Apotex Recent Development Table 106. Sun Pharmaceutical Company Information Table 107. Sun Pharmaceutical Business Overview Table 108. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Sun Pharmaceutical Gabapentin Product Portfolio Table 110. Sun Pharmaceutical Recent Development Table 111. Aurobindo Pharma Company Information Table 112. Aurobindo Pharma Business Overview Table 113. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Aurobindo Pharma Gabapentin Product Portfolio Table 115. Aurobindo Pharma Recent Development Table 116. Intas Company Information Table 117. Intas Business Overview Table 118. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Intas Gabapentin Product Portfolio Table 120. Intas Recent Development Table 121. Amneal Company Information Table 122. Amneal Business Overview Table 123. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Amneal Gabapentin Product Portfolio Table 125. Amneal Recent Development Table 126. Marksans Pharma Company Information Table 127. Marksans Pharma Business Overview Table 128. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Marksans Pharma Gabapentin Product Portfolio Table 130. Marksans Pharma Recent Development Table 131. Glenmark Company Information Table 132. Glenmark Business Overview Table 133. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Glenmark Gabapentin Product Portfolio Table 135. Glenmark Recent Development Table 136. Alkem Company Information Table 137. Alkem Business Overview Table 138. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Alkem Gabapentin Product Portfolio Table 140. Alkem Recent Development Table 141. Jiangsu Enhua Company Information Table 142. Jiangsu Enhua Business Overview Table 143. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Jiangsu Enhua Gabapentin Product Portfolio Table 145. Jiangsu Enhua Recent Development Table 146. Jiangsu Hengrui Company Information Table 147. Jiangsu Hengrui Business Overview Table 148. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. Jiangsu Hengrui Gabapentin Product Portfolio Table 150. Jiangsu Hengrui Recent Development Table 151. Sailike Company Information Table 152. Sailike Business Overview Table 153. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 154. Sailike Gabapentin Product Portfolio Table 155. Sailike Recent Development Table 156. North America Gabapentin Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 157. North America Gabapentin Sales by Country (2021-2026) & (M Unit) Table 158. North America Gabapentin Sales Market Share by Country (2021-2026) Table 159. North America Gabapentin Sales Forecast by Country (2027-2032) & (M Unit) Table 160. North America Gabapentin Sales Market Share Forecast by Country (2027-2032) Table 161. North America Gabapentin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Gabapentin Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Gabapentin Market Share by Country (2021-2026) Table 164. North America Gabapentin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Gabapentin Market Share Forecast by Country (2027-2032) Table 166. Europe Gabapentin Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 167. Europe Gabapentin Sales by Country (2021-2026) & (M Unit) Table 168. Europe Gabapentin Sales Market Share by Country (2021-2026) Table 169. Europe Gabapentin Sales Forecast by Country (2027-2032) & (M Unit) Table 170. Europe Gabapentin Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Gabapentin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Gabapentin Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Gabapentin Market Share by Country (2021-2026) Table 174. Europe Gabapentin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Gabapentin Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Gabapentin Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Gabapentin Sales by Country (2021-2026) & (M Unit) Table 178. Asia-Pacific Gabapentin Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Gabapentin Sales Forecast by Country (2027-2032) & (M Unit) Table 180. Asia-Pacific Gabapentin Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Gabapentin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Gabapentin Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Gabapentin Market Share by Country (2021-2026) Table 184. Asia-Pacific Gabapentin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Gabapentin Market Share Forecast by Country (2027-2032) Table 186. Latin America Gabapentin Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 187. Latin America Gabapentin Sales by Country (2021-2026) & (M Unit) Table 188. Latin America Gabapentin Sales Market Share by Country (2021-2026) Table 189. Latin America Gabapentin Sales Forecast by Country (2027-2032) & (M Unit) Table 190. Latin America Gabapentin Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Gabapentin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Gabapentin Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Gabapentin Market Share by Country (2021-2026) Table 194. Latin America Gabapentin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Gabapentin Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Gabapentin Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Gabapentin Sales by Country (2021-2026) & (M Unit) Table 198. Middle East and Africa Gabapentin Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Gabapentin Sales Forecast by Country (2027-2032) & (M Unit) Table 200. Middle East and Africa Gabapentin Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Gabapentin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Gabapentin Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Gabapentin Market Share by Country (2021-2026) Table 204. Middle East and Africa Gabapentin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Gabapentin Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Gabapentin Distributors List Table 209. Gabapentin Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Gabapentin Image Figure 2. Global Gabapentin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabapentin Market Size (2021-2032) & (US$ Million) Figure 4. Global Gabapentin Sales (2021-2032) & (M Unit) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (M Unit) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (M Unit) Figure 9. Global Gabapentin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Gabapentin Market Share by Type 2025 VS 2032 Figure 11. North America Gabapentin Sales Market Share in Volume by Type in 2025 Figure 12. North America Gabapentin Sales Market Share in Value by Type in 2025 Figure 13. Europe Gabapentin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Gabapentin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Gabapentin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Gabapentin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Gabapentin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Gabapentin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Gabapentin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Gabapentin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Gabapentin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Epilepsy Image Figure 24. Global Epilepsy Sales YoY Growth (2021-2032) & (M Unit) Figure 25. Neuropathic Pain Image Figure 26. Global Neuropathic Pain Sales YoY Growth (2021-2032) & (M Unit) Figure 27. Restless Legs Syndrome Image Figure 28. Global Restless Legs Syndrome Sales YoY Growth (2021-2032) & (M Unit) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (M Unit) Figure 31. Global Gabapentin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Gabapentin Market Share by Application 2025 VS 2032 Figure 33. North America Gabapentin Sales Market Share in Volume by Application in 2025 Figure 34. North America Gabapentin Sales Market Share in Value by Application in 2025 Figure 35. Europe Gabapentin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Gabapentin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Gabapentin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Gabapentin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Gabapentin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Gabapentin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Gabapentin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Gabapentin Sales Market Share in Value by Application in 2025 Figure 43. North America Gabapentin Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 44. North America Gabapentin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Gabapentin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Gabapentin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gabapentin Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 48. Europe Gabapentin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gabapentin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Gabapentin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gabapentin Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 52. Asia-Pacific Gabapentin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gabapentin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Gabapentin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gabapentin Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 56. Latin America Gabapentin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gabapentin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Gabapentin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gabapentin Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 60. Middle East and Africa Gabapentin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gabapentin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Gabapentin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Gabapentin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Gabapentin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
Applications
  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome
  • Others
Companies covered
  • Pfizer
  • Assertio Therapeutics
  • TEVA
  • Mylan
  • Arbor Pharma
  • Novartis
  • Apotex
  • Sun Pharmaceutical
  • Aurobindo Pharma
  • Intas
  • Amneal
  • Marksans Pharma
  • Glenmark
  • Alkem
  • Jiangsu Enhua
  • Jiangsu Hengrui
  • Sailike

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gabapentin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gabapentin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gabapentin Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Tablet
  8. 1.4 Global Gabapentin Market Size by Type
  9. 1.4.1 Global Gabapentin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Gabapentin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Gabapentin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Gabapentin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Gabapentin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Gabapentin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Gabapentin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Gabapentin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gabapentin Industry Trends
  2. 2.2 Gabapentin Industry Drivers
  3. 2.3 Gabapentin Industry Opportunities and Challenges
  4. 2.4 Gabapentin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gabapentin Revenue (2021-2026)
  2. 3.2 Global Top Players by Gabapentin Sales (2021-2026)
  3. 3.3 Global Top Players by Gabapentin Price (2021-2026)
  4. 3.4 Global Gabapentin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gabapentin Major Company Production Sites & Headquarters
  6. 3.6 Global Gabapentin Company, Product Type & Application
  7. 3.7 Global Gabapentin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gabapentin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gabapentin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gabapentin Tier 1, Tier 2, and Tier 3
4 Gabapentin Regional Status and Outlook
  1. 4.1 Global Gabapentin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gabapentin Historic Market Size by Region
  3. 4.2.1 Global Gabapentin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gabapentin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gabapentin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gabapentin Forecasted Market Size by Region
  7. 4.3.1 Global Gabapentin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gabapentin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gabapentin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gabapentin by Application
  1. 5.1 Gabapentin Market by Application
  2. 5.1.1 Epilepsy
  3. 5.1.2 Neuropathic Pain
  4. 5.1.3 Restless Legs Syndrome
  5. 5.1.4 Others
  6. 5.2 Global Gabapentin Market Size by Application
  7. 5.2.1 Global Gabapentin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Gabapentin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Gabapentin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Gabapentin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Gabapentin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Gabapentin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Gabapentin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Gabapentin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Gabapentin Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Assertio Therapeutics
  8. 6.2.1 Assertio Therapeutics Company Information
  9. 6.2.2 Assertio Therapeutics Business Overview
  10. 6.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Assertio Therapeutics Gabapentin Product Portfolio
  12. 6.2.5 Assertio Therapeutics Recent Developments
  13. 6.3 TEVA
  14. 6.3.1 TEVA Company Information
  15. 6.3.2 TEVA Business Overview
  16. 6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TEVA Gabapentin Product Portfolio
  18. 6.3.5 TEVA Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Gabapentin Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Arbor Pharma
  26. 6.5.1 Arbor Pharma Company Information
  27. 6.5.2 Arbor Pharma Business Overview
  28. 6.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Arbor Pharma Gabapentin Product Portfolio
  30. 6.5.5 Arbor Pharma Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Gabapentin Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Apotex
  38. 6.7.1 Apotex Company Information
  39. 6.7.2 Apotex Business Overview
  40. 6.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Apotex Gabapentin Product Portfolio
  42. 6.7.5 Apotex Recent Developments
  43. 6.8 Sun Pharmaceutical
  44. 6.8.1 Sun Pharmaceutical Company Information
  45. 6.8.2 Sun Pharmaceutical Business Overview
  46. 6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Recent Developments
  49. 6.9 Aurobindo Pharma
  50. 6.9.1 Aurobindo Pharma Company Information
  51. 6.9.2 Aurobindo Pharma Business Overview
  52. 6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aurobindo Pharma Gabapentin Product Portfolio
  54. 6.9.5 Aurobindo Pharma Recent Developments
  55. 6.10 Intas
  56. 6.10.1 Intas Company Information
  57. 6.10.2 Intas Business Overview
  58. 6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Intas Gabapentin Product Portfolio
  60. 6.10.5 Intas Recent Developments
  61. 6.11 Amneal
  62. 6.11.1 Amneal Company Information
  63. 6.11.2 Amneal Business Overview
  64. 6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Amneal Gabapentin Product Portfolio
  66. 6.11.5 Amneal Recent Developments
  67. 6.12 Marksans Pharma
  68. 6.12.1 Marksans Pharma Company Information
  69. 6.12.2 Marksans Pharma Business Overview
  70. 6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Marksans Pharma Gabapentin Product Portfolio
  72. 6.12.5 Marksans Pharma Recent Developments
  73. 6.13 Glenmark
  74. 6.13.1 Glenmark Company Information
  75. 6.13.2 Glenmark Business Overview
  76. 6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Glenmark Gabapentin Product Portfolio
  78. 6.13.5 Glenmark Recent Developments
  79. 6.14 Alkem
  80. 6.14.1 Alkem Company Information
  81. 6.14.2 Alkem Business Overview
  82. 6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Alkem Gabapentin Product Portfolio
  84. 6.14.5 Alkem Recent Developments
  85. 6.15 Jiangsu Enhua
  86. 6.15.1 Jiangsu Enhua Company Information
  87. 6.15.2 Jiangsu Enhua Business Overview
  88. 6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Jiangsu Enhua Gabapentin Product Portfolio
  90. 6.15.5 Jiangsu Enhua Recent Developments
  91. 6.16 Jiangsu Hengrui
  92. 6.16.1 Jiangsu Hengrui Company Information
  93. 6.16.2 Jiangsu Hengrui Business Overview
  94. 6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
  96. 6.16.5 Jiangsu Hengrui Recent Developments
  97. 6.17 Sailike
  98. 6.17.1 Sailike Company Information
  99. 6.17.2 Sailike Business Overview
  100. 6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sailike Gabapentin Product Portfolio
  102. 6.17.5 Sailike Recent Developments
7 North America by Country
  1. 7.1 North America Gabapentin Sales by Country
  2. 7.1.1 North America Gabapentin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gabapentin Sales by Country (2021-2026)
  4. 7.1.3 North America Gabapentin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gabapentin Market Size by Country
  6. 7.2.1 North America Gabapentin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gabapentin Market Size by Country (2021-2026)
  8. 7.2.3 North America Gabapentin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gabapentin Sales by Country
  2. 8.1.1 Europe Gabapentin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gabapentin Sales by Country (2021-2026)
  4. 8.1.3 Europe Gabapentin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gabapentin Market Size by Country
  6. 8.2.1 Europe Gabapentin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gabapentin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gabapentin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gabapentin Sales by Country
  2. 9.1.1 Asia-Pacific Gabapentin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gabapentin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gabapentin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gabapentin Market Size by Country
  6. 9.2.1 Asia-Pacific Gabapentin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gabapentin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gabapentin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gabapentin Sales by Country
  2. 10.1.1 South America Gabapentin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gabapentin Sales by Country (2021-2026)
  4. 10.1.3 South America Gabapentin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gabapentin Market Size by Country
  6. 10.2.1 South America Gabapentin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gabapentin Market Size by Country (2021-2026)
  8. 10.2.3 South America Gabapentin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gabapentin Sales by Country
  2. 11.1.1 Middle East and Africa Gabapentin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gabapentin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gabapentin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gabapentin Market Size by Country
  6. 11.2.1 Middle East and Africa Gabapentin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gabapentin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gabapentin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gabapentin Value Chain Analysis
  2. 12.1.1 Gabapentin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gabapentin Production Mode & Process
  7. 12.2 Gabapentin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gabapentin Distributors
  10. 12.2.3 Gabapentin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst